| CFH |
P08603
|
complement factor H
|
|
0.86 |
0.441 |
0.885 |
16
|
51 |
| APOB |
P04114
|
apolipoprotein B
|
|
1.9E-16 |
0.453 |
0.808 |
16
|
16 |
| APOH |
P02749
|
apolipoprotein H
|
|
1.6E-15 |
0.563 |
0.769 |
16
|
11 |
| TXNL4B |
Q9NX01
|
thioredoxin like 4B
|
|
4.4E-03 |
0.931 |
0.077 |
15
|
9 |
| CCDC91 |
Q7Z6B0
|
coiled-coil domain containing 91
|
|
3.8E-06 |
0.729 |
0.423 |
15
|
19 |
| C9 |
P02748
|
complement C9
|
|
1.6E-24 |
0.619 |
0.692 |
15
|
24 |
| CADM3-AS1 |
|
CADM3 antisense RNA 1
|
|
|
1.000 |
0.038 |
14
|
8 |
| MSH5-SAPCD1 |
|
MSH5-SAPCD1 readthrough (NMD candidate)
|
|
|
0.760 |
0.423 |
14
|
10 |
| DENND4A |
Q7Z401
|
DENN domain containing 4A
|
|
1.00 |
0.821 |
0.192 |
14
|
19 |
| BOC |
Q9BWV1
|
BOC cell adhesion associated, oncogene regulated
|
|
1.7E-07 |
0.666 |
0.423 |
14
|
5 |
| NRXN3 |
Q9HDB5 Q9Y4C0
|
neurexin 3
|
|
1.00 |
0.656 |
0.615 |
14
|
16 |
| PLXNC1 |
O60486
|
plexin C1
|
|
1.00 |
0.722 |
0.269 |
13
|
11 |
| AQP4-AS1 |
|
AQP4 antisense RNA 1
|
|
|
0.751 |
0.577 |
13
|
15 |
| FAM227B |
Q96M60
|
family with sequence similarity 227 member B
|
|
4.3E-23 |
0.792 |
0.154 |
13
|
9 |
| R3HDM2 |
Q9Y2K5
|
R3H domain containing 2
|
|
1.00 |
0.760 |
0.346 |
13
|
11 |
| ITGA1 |
P56199
|
integrin subunit alpha 1
|
|
2.6E-16 |
0.644 |
0.654 |
13
|
11 |
| MICB |
Q29980
|
MHC class I polypeptide-related sequence B
|
|
4.1E-05 |
0.576 |
0.731 |
13
|
7 |
| NCAM1 |
P13591
|
neural cell adhesion molecule 1
|
|
1.00 |
0.415 |
0.885 |
13
|
25 |
| CFB |
P00751
|
complement factor B
|
|
4.7E-16 |
0.532 |
0.769 |
13
|
11 |
| BSN |
Q9UPA5
|
bassoon presynaptic cytomatrix protein
|
|
1.00 |
0.769 |
0.308 |
13
|
17 |
| MICA |
Q29983
|
MHC class I polypeptide-related sequence A
|
|
5.0E-03 |
0.473 |
0.846 |
12
|
9 |
| LINC02571 |
|
long intergenic non-protein coding RNA 2571
|
|
|
0.743 |
0.500 |
12
|
12 |
| CD300LF |
Q8TDQ1
|
CD300 molecule like family member f
|
|
1.1E-08 |
0.716 |
0.385 |
12
|
10 |
| RAB37 |
Q96AX2
|
RAB37, member RAS oncogene family
|
|
8.1E-08 |
0.760 |
0.231 |
12
|
14 |